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Abstract
Stone disease is a unique condition that requires appropriate management in a timely manner as it can result in both emergent 
conditions and long term effects on kidney functions. In this study it is aimed to identify the up-to-date practice patterns 
related to preoperative evaluation and anesthesia for stone disease interventions during COVID-19 pandemic. The data of 473 
patients from 11 centers in 5 different countries underwent interventions for urinary stones during the Covid-19 pandemic 
was collected and analyzed retrospectively. Information on the type of the stone related conditions, management strategies, 
anesthesiologic evaluation, anesthesia methods, and any alterations related to COVID-19 pandemic was collected. During 
the preoperative anesthesia evaluation thorax CT was performed in 268 (56.7%) and PCR from nasopharyngeal swab was 
performed in 31 (6.6%) patients. General anesthesia was applied in 337 (71.2%) patients and alteration in the method of 
anesthesia was recorded in 45 (9.5%) patients. A cut-off value of 21 days was detected for the hospitals to adapt changes 
related to COVID-19. Rate of preoperative testing, emergency procedures, conservative approaches and topical/regional anes-
thesia increased after 21 days. The preoperative evaluation for management of urinary stone disease is significantly affected 
by COVID-19 pandemic. There is significant alteration in anesthesia methods and interventions. The optimal methods for 
preoperative evaluation are still unknown and there is discordance between different centers. It takes 21 days for hospitals 
and surgeons to adapt and develop new strategies for preoperative evaluation and management of stones.
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The coronavirus disease 2019 (COVID-19) emerged from 
Wuhan, China in December 2019 and became a global 
health problem [1]. This viral infection mainly affects 
the pulmonary system and due to the highly contagious 
nature of the disease certain considerations raised regard-
ing the anesthesiology procedures in the era of pandemic 
[2–4]. As the asymptomatic patients can spread the virus 
even during the incubation period [5], the perioperative 
evaluation of all cases is of upmost importance for both 
the patients and the health care professionals.
Limited experience accumulated during the Covid-19 
pandemic era demonstrated that the management of all 
medical conditions including surgical procedures were 
altered to a certain extent. In a recent publication, Ficarra 
et al. advised the suspension of non-emergency urological 
interventions and the expert panel suggested recommen-
dations for the organization of surgical cases [6]. Stone 
disease is a unique condition which can cause emergency 
conditions and also adverse effects on the kidney func-
tion during long-term follow-up. Therefore, appropriate 
management in a timely manner is crucial. Approach to 
urinary stones and related conditions can vary from major 
surgeries under general anesthesia (i.e. percutaneous neph-
rolithotomy) to less invasive applications under local anes-
thesia (i.e. nephrostomy placement). It has been recently 
shown that the practice patterns for stone disease also were 
altered due to COVID-19 pandemic [7].
Clinical decision making for urinary stone cases not 
only depends on the patient and stone related factors but 
also on the other disciplines and health care resources 
including anesthesiologists, hospital beds, mechanical 
ventilators and intensive care units. During the extraordi-
nary conditions of Covid-19 pandemic, the ideal strategies 
for management of stone disease in an individualized man-
ner is unknown and also there is no information in the pub-
lished literature regarding the anesthesiology perspectives.
The aims of this study are: a. to identify the up-to-date 
practice patterns related to preoperative evaluation and 
anesthesia applied for the management of stones and b. 
assess the possible different approaches among centers 
from different parts of the world.
Materials and methods
The data of 473 patients from 11 centers in 5 different 
countries underwent interventions for urinary stones dur-
ing the Covid-19 pandemic was collected and analyzed ret-
rospectively. Six of the centers (Ankara University School 
of Medicine Department of Urology, Ankara (n = 29), 
Necmettin Erbakan University, Meram School of Medi-
cine Department of Urology, Konya (n = 48), Health Sci-
ences University, Dr. Lütfi Kirdar Training and Research 
Hospital, Istanbul (n = 42), Medipol University School 
of Medicine Department of Urology, Istanbul (n = 17), 
Koç University School of Medicine Department of Urol-
ogy, Istanbul (n = 13), and Istanbul University School of 
Medicine Department of Urology, Istanbul (n = 5)) were 
from Turkey and there were two center from Italy [Uni-
versità Vita-Salute San Raffaele, Division of Experimental 
Oncology/Unit of Urology (n = 4) and Department of Urol-
ogy Foundation IRCCS Ca’ Granda Ospedale Maggiore 
Policlinico (n = 5)]. There were also single centers from 
China [The First Affiliated Hospital of Guangzhou Medi-
cal University, Guangzhou (n = 250)], Greece [University 
of Patras School of Medicine Department of Urology, 
Patras (n = 38)], and Bulgaria [Military Medical Academy, 
Department of Urology and Nephrology, Sofia (n = 22)]. 
Among the patients, 223 of them were from European 
centers whereas 250 patients were from China.
The recorded data included patient demographics, pre-
operative symptoms and history of exposure to Covid-19. 
Also data related to presence of urinary stones, type of the 
intervention, emergency status of the intervention together 
with if there is any alteration in the type of intervention 
related to Covid-19 was questioned. The type of the tests 
during preoperative anesthesiology assessment together 
with their results were recorded. The method of anesthesia 
for each intervention was recorded and any alteration in the 
anesthesia method related to Covid-19 was also questioned. 
Further information on follow-up of the patients in terms of 
both stone disease related status and Covid-19 related status 
was also collected.
The primary end point of the study was to collect infor-
mation on the type of the stone related conditions, manage-
ment strategies, anesthesiologic evaluation, anesthesia meth-
ods, and any alterations related to COVID-19 pandemic. The 
secondary end point was to determine if there is any differ-
ence in practice patterns between the European centers and 
Chinese center which would indicate a time related altera-
tion in practice patterns.
Statistics
The Statistical analysis was performed using the IBM Sta-
tistical Package for the Social Sciences version 20.0 (IBM 
SPSS Statistics for Windows, Version 20.0. Armonk, NY, 
USA) The normal distribution of the continuous variables 
was tested using the Kolmogorov–Smirnov test. The data 
was mainly presented as descriptive statistics. To evaluate 
the effect of time on practice patterns, Receiver Observer 
Characteristics (ROC) analysis was performed. The patients 
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were grouped with respect to the cut-off date from the obser-
vation of the first case in a country. The chi-squared test was 
used to compare categorical variables, and Student’s t-test 
was applied to compare continuous variables among groups. 
A p-value < 0.05 was accepted as statistically significant.
Results
The main age of the population was 51.4 ± 14.1  years 
and mean days from the report of the first case in the 
particular country to the stone related intervention was 
35.5 ± 24.2 days. Regarding gender, 296 (62.6%) of the 
patients were males and 177 (37.4%) of the patients were 
females. Suspicious history of exposure to COVID-19 (+) 
patients was not present in any of the patients and no symp-
toms were present in 468 (98.9%) of the patients. During 
first presentation fever was positive in three patients, myal-
gia was positive in one patient and fatigue with fever was 
present in one patient. Positive test result related to COVID-
19 was not reported in any of these symptomatic patients. 
The demographic and stone disease related data of the entire 
population is summarized in Table 1.
Kidney stone was the most common stone related situa-
tion (38.5%) while ureteral stone was present in 23.9% of the 
patients. Multiple stones located both in kidney and ureter 
was also present 21.9% of the cases and obstructive pyelo-
nephritis was present in 9.8% of the patients. An emergency 
intervention was performed in 109 (23%) patients and the 
most common procedure performed was ureteroscopic stone 
extraction (34.5%). Any alteration in the choice of stone 
related procedure was reported in 33 (7%) of the patients. 
The data on location of stones in the collecting system and 
preoperative stone related clinical conditions together with 
the performed interventions is summarized in Table 2.
During the preoperative anesthesia evaluation, additional 
testing was performed in 282 (59.6%) patients. The most 
commonly performed additional test was computerized 
tomography (CT) scan of the chest and was performed in 
268 (56.7%) patients. PCR from the nasopharyngeal swab 
was performed in 31 (6.6%) patients and rapid antigen/anti-
body testing was performed in only one patient. A positive 
test result in any of the tests was not reported in any of the 
patients. Regarding the anesthesia methods, general anesthe-
sia either by intra-tracheal general anesthesia or laryngeal 
mask airway was applied in 337 (71.2%) patients. Spinal/
epidural anesthesia was performed in 76 (16.1%) and topi-
cal/local anesthesia was performed in 52 (11%) patients. 
Any alteration in the method of anesthesia was recorded 
in 45 (9.5%) of the patients. The data related to anesthesia 
evaluation and practice is summarized in Table 3.
To evaluate the effect of time (from the first reported 
COVID-19 case to stone related intervention) on the anes-
thesia evaluation, ROC analysis was performed. A cut-off 
value of 21 days (sensitivity: 90.8% and specificity:82.2%) 
was detected for performing an additional diagnostic test 
for COVID-19 preoperatively. Additional tests were per-
formed preoperatively in 14.2% of the patients operated 
within ≤ 21 days and in 88.3% of the patients operated after 
21 days (p < 0.0001). PCR from nasopharynx swabs was 
performed in 3.8% and 8.3% of the patients in the ≤ 21 days 
and > 21 days groups respectively and the difference was 
not statistically significant (p = 0.059). However, the rate of 
Table 1  The demographic and stone disease related data of the entire 
population
Parameter Outcome
Mean age ± SD (years) 51.4 ± 14.1
Mean days to intervention ± SD (days) 35.5 ± 24.2
Preoperative COVID-19 related symptom, n(%)
 No symptom 468 (98.9)
 Fever 3 (0.6%)
 Myalgia 1 (0.2%)
 Fatigue and fever 1 (0.2%)
 Suspicious exposure to COVID-19, n(%) 0 (0%)
Table 2  The stone related situation and the interventions of the entire 
population
Parameter Outcome n(%)
Stone related situation n(%) N = 473
Kidney stone 182 (38.5)
Ureter stone 113 (23.9)
Kidney and ureter stone 104 (21.9)
Obstructed pyelonephritis 46 (9.8)
Previously placed JJ stent 28 (5.9)
Emergency intervention n(%) N = 473
 Yes 109 (23)
 No 364 (77)
Type of intervention N = 460
Nephrostomy placement 12 (2.6)
JJ stent insertion 82 (17.8)
Ureteroscopic stone extraction 163 (35.4)
Retrograde intrarenal surgery 26 (5.7)
Percutaneous nephrolithotomy 139 (30.2)
Endoscopy Combined intrarenal surgery 9 (2)
JJ stent extraction (auxiliary procedure) 28 (6.1)
Laparoscopic ureterolithotomy –
Open surgery 1 (0.2)
SWL –





chest CT scan was significantly higher in the latter group 
(84.5% vs. 12.6%, p < 0.0001). The rates of alterations in 
the anesthesia method were also similar (11.5% vs. 8.3%, 
p = 0.263). The rates of emergency procedures were 35% vs. 
15.5% in the ≤ 21 days and > 21 days groups respectively and 
the difference was statistically significant (p < 0.001). The 
rates of alteration of stone related procedures were similar 
(7.1% vs. 6.9%, p = 1.000). The results are summarized in 
Fig. 1.
The cohorts from European centers and Chinese center 
were also evaluated separately. As expected, the mean time 
to stone related intervention was significantly longer in 
the Chinese cohort (53.3 ± 16.8 days vs. 15.5 ± 13.2 days, 
p < 0.0001). During preoperative evaluation, all of the 
patients in the Chinese cohort underwent chest CT and 
any other testing was not performed. Also no alterations 
in method of anesthesia or stone related intervention was 
reported related to COVID-19 pandemic.
However, in the European cohort, chest CT was per-
formed in 18 (8.1%) and PCR from nasopharyngeal swabs 
was performed in 31 (13.9%) of the 223 patients. Altera-
tion in the anesthesia method and stone related interventions 
were reported in 32 (14.3%) and 33 (14.8%) patients respec-
tively. Additionally, the alterations in the European cohort 
became prominent with the cut-off value of 21 days. Addi-
tional testing during preoperative anesthesia evaluation was 
performed in 24 of the 58 (41.4%) patients and 8 of the 165 
patients (4.8%) in the > 21 days and ≤ 21 days groups respec-
tively (p < 0.0001). Similarly, the rate of alteration in the 
anesthesia method was significantly higher in the > 21 days 
group (41.4% vs. 12.7%, p < 0.0001) and rate of alteration 
in the stone related procedure was also significantly higher 
in the > 21 days group (34.5% vs. 7.9%, p < 0.0001). Results 
are summarized in Fig. 2. In the European cohort the rate of 
the patients underwent an emergency intervention increased 
significantly after the cut-off value of 21 days (38.8% vs. 
76.6%, p < 0.0001). Also regarding the applied anesthesia 
method, 53.5% of the patients underwent topical or regional 
anesthesia in the > 21 days group, while the rate was 41.2% 
among patients operated in ≤ 21 days group (p = 0.0001).
In the European cohort the type of interventions also 
shifted to more conservative options. In the ≤ 21 days group, 
the rate of definitive surgical options such as ureteroscopic 
stone extraction, retrograde intrarenal surgery, and percu-
taneous nephrolithotomy was 61.8% and rate of conserva-
tive approaches such as nephrostomy placement, JJ stent 
placement or JJ stent extraction as an ancillary procedure 
Table 3  The data related to anesthesia evaluation and practice of the 
entire population
Parameter Outcome n(%)
Addtional testing during anesthesia evaluation n(%) 282 (59.6)
PCR test from nasopharyngeal swab 31 (6.6)
Rapid antigen/antibody test 1 (0.2)
Thorax CT scan 268 (56.7)
Anesthesia method n(%)
Topical/local anesthesia 52 (11)
Spinal/epidural anesthesia 76 (16.1%)
Laryngeal mask airway 167 (35.3)
Intra-tracheal intubation 170 (35.9)
Sedation 8 (1.7)
Alteration in anesthesia method n(%)
 Yes 45 (9.5)
 No 428 (90.5)
Fig. 1  Summary of preoperative 
additional testing, alteration in 
anesthesia method and stone 




was 38.2%. However, in the > 21 days group, there was a 
significantly higher tendency for conservative or ancillary 
procedures (81%) compared to definitive treatments (19%) 
(p < 0.0001). This shifting to more conservative approaches 
was parallel with higher rate of patient admissions for emer-
gent conditions after 21 days. In the ≤ 21 days group, kid-
ney stones were the leading clinical condition (37.6%) with 
previously scheduled definitive treatments. However, the 
leading cause of hospital admissions was obstructive pyelo-
nephritis in 37.9% of the cases in > 21 days group, which 
required nephrostomy tube or JJ stent placement.
During the follow up two patients developed fever post-
operatively. The nasopharyngeal swap PCR and chest CT 
studies revealed COVID-19 (+) results. Elongated hospi-
talization related to stone disease was observed in 15 (3.2%) 
of the patients.
Discussion
As a pulmonary infection causing lethal conditions, COVID-
19 pandemic affected not only the infected patients but its 
consequences has also altered the entire health care sys-
tem. While the cases with an elective surgery plan were 
postponed in the majority of the centers; emergency cases 
together with oncological surgeries are advised to be per-
formed with precautions [6]. Among other non-oncological 
urological disorders, as a common pathology stone disease 
carries the risk of potential to become an emergency con-
dition and also obstructing calculi may cause detrimental 
effects on kidney functions if not treated on time with an 
appropriate management plan. Therefore, successful removal 
of such stones on time is highly crucial.
Regarding the unexpected and underestimated involve-
ment of the world as well as modern medicine with COVID-
19 pandemic in a truly unprepared status; many questions 
arose with respect to preoperative patient evaluation, as there 
was no standard approach and/or recommendations during 
problematic days. For this reason, surgeons were obliged to 
make their own decisions during the preoperative evalua-
tion at the beginning of the pandemic and then began to act 
according to internal regulations of their institutions and 
internal guidelines of their countries. Related with this issue, 
although some national and international organizations 
began to report their recommendations based on their lim-
ited experience obtained; there is still no consensus between 
such organizations to give reliable, established guidance to 
practicing surgeons [8].
In addition to the patient evaluation, challenges are being 
faced also during preoperative anesthesia preparation pro-
cess in this controversial situation. Aside from the cases with 
a positive COVID-19 diagnosis, the asymptomatic patients 
or the ones within the incubation period may cause trans-
mission of the viral infection to the healthcare professionals 
and other patients. On the other hand again, due to the direct 
exposure to the airway of the patients, anesthesiologists are 
at great risk for being infected during interventions [9]. In a 
recent study, Lie et al. stated that regional anesthesia on this 
aspect could provide a successful anesthesia for the patient 
and be helpful in the protection for the anesthesiology team 
[10]. However, Baig et al. also reported that COVID-19 
virus can involve the central nervous system [11] and viral 
transmission could be possible during regional anesthesia 
as well. Therefore, it is obvious that relying on the safety 
of regional anesthesia does not provide complete protection 
for the health care professionals and principles for optimal 
preoperative evaluation during the pandemic need to be 
determined.
The two prominent tests performed to screen COVID-
19 virus during preoperative evaluation are PCR from a 
nasopharyngeal swab and chest CT scan [12, 13]. While 
some guidelines suggest PCR testing in suspicious cases, the 
guidelines for sections with a high likelihood of virus load, 
such as otolaryngology, suggest that it can be performed 
Fig. 2  Summary of preoperative 
additional testing, alteration in 
anesthesia method and stone 




in all patients [14]. The rate of PCR testing was 6.6% in our 
cohort without any positive result preoperatively. Chest CT 
was commonly applied in preoperative evaluation during 
the pandemic due to the fact that it can demonstrate relevant 
objective, indicative changes in the affected lungs even in 
the PCR false-negative patients [13]. In our cohort, a CT 
scan was applied in 268 (56.7%) patients in the absence of 
a positive result detected by any means. Among these 268 
patients, 250 of them were operated in China and this result 
is concordant with the result of a recent meta-analysis indi-
cating the low prevalence of screening with chest CT outside 
of China [15]. Also Chinese national guidelines advocate 
chest CT examination in every admitted patient for surgery 
[16]. However, taking the reported respective sensitivity and 
specificity of chest CT as 94% and 37% into account, some 
long term detrimental consequences of radiation exposure 
necessitates its application with caution as well [15]. In our 
cohort two patients without a preoperative adequate screen-
ing were diagnosed postoperatively with positive test results 
for COVID-19 in both PCR and CT scan evaluations.
The Chinese perspective for preoperative screening was 
performing a CT scan in all patients without PCR testing. 
Interestingly, neither anesthesia method, nor treatment strat-
egy was altered in the Chinese center. This could be due to 
the fact that the Chinese authorities had a better COVID-19 
control or the recommendations on this aspect were pub-
lished a while later from the beginning of the COVID-19 
in China [17]. In out trial, we also investigated the change 
in practice patterns related to time and the ROC analysis 
revealed 21 days as the cut-off. Among patients operated in 
Europe the rate of additional testing significantly increased 
after 21 days (4.8% vs. 41.4%). Therefore we believe that 
it took at least 21 days for the hospital regulations to be 
evolved and surgeons to get adapted to the pandemic situ-
ation. This is also in accordance with the increased rate of 
emergency procedures (38.8% vs. 76.6%) and decreased rate 
of general anesthesia (58.8% vs. 46.5%) after 21 days in the 
European cohort.
In the entire cohort, the rate of alteration in the stone 
related interventions was found to be only 7%. However, this 
rate was also higher in European cohort (14.8%) and signifi-
cantly increased from 7.9 to 34.5% after 21 days. Also, there 
was a tendency to perform more conservative approaches 
such as nephrostomy tube or JJ stent placement rather than 
definitive treatment options namely ureterorenoscopy or per-
cutaneous nephrolithotomy in the > 21 days group. There-
fore, our findings indicate well that after 21 days of time 
period following the diagnosis of first case, the rate of test-
ing performed for preoperative screening, number of cases 
treated in an emergency basis and also the alterations in 
type of interventions were all increased. While conserva-
tive approaches became preferred alternatives in the same 
period, number of cases treated under general anesthesia did 
decrease to a certain extent. This shift after 21 days may be 
explained by increased COVID-19 workload in the urology 
departments of hospitals and also avoidance of definitive 
treatment options requiring general anesthesia and mechani-
cal ventilation.
Conclusions
The preoperative evaluation prior to the management of 
urinary stones has been found to be affected well by the 
COVID-19 pandemic. Significant alterations in preferred 
anesthesia methods and stone related interventions were also 
noted. However, the optimal methods for preoperative evalu-
ation are still unknown and there is discordance between 
different centers. It took 21 days for hospitals and surgeons 
to adapt and develop new strategies for preoperative evalu-
ation and management of stones.
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